RO 📈 Roche Holding AG - Overview

Rocher Holding AG is a Swiss multinational healthcare company that operates globally, with a presence in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company's pharmaceutical division develops and commercializes a wide range of medicines in various therapeutic areas, including anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune diseases, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

Rocher's pharmaceutical portfolio includes both established brands and innovative new treatments, with a focus on improving patient outcomes and addressing unmet medical needs. The company is also committed to investing in research and development, with a pipeline of promising new products in various stages of development.

In addition to its pharmaceutical business, Roche Holding AG is a leading provider of in vitro diagnostics, offering a broad range of tests and instruments for the diagnosis of various diseases, including cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other conditions. The company's diagnostic solutions are designed to provide accurate and reliable results, enabling healthcare professionals to make informed treatment decisions.

Rocher's diagnostic portfolio also includes digital health solutions, which leverage advanced technologies such as artificial intelligence and machine learning to improve patient care and outcomes. These solutions include data analytics platforms, remote monitoring systems, and other digital tools that support personalized medicine and precision healthcare.

Founded in 1896, Roche Holding AG is headquartered in Basel, Switzerland, and has a long history of innovation and excellence in the healthcare industry. Today, the company is a global leader in pharmaceuticals and diagnostics, with a commitment to improving lives and transforming healthcare.